Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Instat is a topical hemostatic agent composed of purified bovine dermal collagen, designed for use in surgical procedures to control bleeding when conventional methods like pressure or ligatures are ineffective. Developed by Ethicon, a subsidiary of Johnson & Johnson, Instat provides a mechanical matrix that facilitates the rapid adhesion and aggregation of platelets upon contact with blood. This interaction triggers the intrinsic coagulation cascade, leading to the formation of a stable fibrin clot. The product is biocompatible and fully absorbable, typically being resorbed by the body within 4 to 6 weeks. It is available in various forms, such as sponges and pads, and is widely utilized across surgical specialties including general, vascular, and orthopedic surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Instat.